Single Ventricle Physiology and Common Viral Illness: A Medical-Legal Guide for Attorneys

Introduction

Few pediatric populations are as medically fragile — or as legally consequential when things go wrong — as children living with single ventricle (SV) physiology. These are children born with only one functional pumping chamber, who survive through a planned series of three staged heart operations and who depend, between and after those operations, on a delicate balance of blood flow that a common childhood illness can tip into collapse.

The medical-legal significance of this group is disproportionate to its size. Single ventricle defects account for only about 8–10% of all congenital heart disease, yet they carry some of the highest childhood morbidity and mortality of any cardiac lesion (Du Toit et al., Pediatric Cardiology, 2026). A routine viral illness — the kind that would be safely sent home in a healthy toddler — can be the proximate event in a catastrophic deterioration in a child with a shunt-dependent or Fontan circulation. When that happens, attorneys are frequently asked to evaluate whether a clinician who saw the child during a seemingly minor illness missed the significance of the underlying anatomy.

This article explains, in plain terms, why these children are so vulnerable to ordinary infections, what the evidence says about recognition and disposition, and where the realistic targets for both plaintiff and defense arguments lie.

Clinical Vignette

A 9-month-old infant with hypoplastic left heart syndrome, status post stage 1 (Norwood) palliation and awaiting the second-stage operation, is brought to an urgent care clinic in winter with two days of nasal congestion, cough, and tactile fever. The parents report the baby is feeding "about half" of normal and is more sleepy than usual.

The clinician documents a temperature of 38.3°C and a respiratory rate noted as "mildly increased." No baseline oxygen saturation is recorded, no heart rate is documented, no weight is obtained, and there is no documentation of hydration status, capillary refill, or peripheral perfusion. The infant is diagnosed with a viral upper respiratory infection and discharged with antipyretic advice. The parents are not given specific instructions about the child's baseline oxygen saturation or when to seek emergency care, and the clinic does not contact the child's cardiology team.

Over the next 24 hours the infant feeds progressively less, becomes lethargic, and is brought by ambulance in shock. Despite resuscitation the infant dies. The clinical picture is attributed to intercurrent viral illness producing hypovolemia and hypoxemia superimposed on a shunt-dependent circulation.

This scenario illustrates the recurring medical-legal question in this population: not whether the viral illness itself was negligently caused, but whether the clinician recognized that in a single ventricle child an ordinary illness demands an extraordinary assessment and a lower threshold for escalation.

What Is Single Ventricle Physiology?

"Single ventricle" is an umbrella term for a group of severe congenital heart defects in which only one ventricle is adequately developed to do meaningful work. The most familiar example is hypoplastic left heart syndrome (HLHS), but the category also includes tricuspid atresia, pulmonary atresia with intact ventricular septum, double-inlet left ventricle, and several heterotaxy-related lesions.

Because one pumping chamber cannot support two separate circulations (to the body and to the lungs) in the normal way, these children undergo a staged surgical palliation, typically in three operations:

• Stage 1 (neonatal period): Often the Norwood operation for HLHS, which establishes reliable blood flow to both the body and the lungs, frequently using a surgical shunt. The period between this operation and stage 2 is called the interstage and is among the highest-risk intervals in all of pediatrics.
• Stage 2 (around 3–6 months): The superior cavopulmonary connection (bidirectional Glenn), which routes blood from the upper body directly to the lungs.
• Stage 3 (around 2–4 years): The Fontan operation, which completes the separation so that venous blood flows passively to the lungs.

Crucially, these operations palliate but do not cure. A child with a completed Fontan circulation remains lifelong at risk for arrhythmias, ventricular dysfunction, protein-losing enteropathy, liver and kidney disease, thromboembolism, and plastic bronchitis (Du Toit et al., Pediatric Cardiology, 2026). Even after a successful Fontan, estimated 20-year survival ranges from roughly 60–85%, and the development of protein-losing enteropathy drops 20-year survival to about 19% (Du Toit et al., Pediatric Cardiology, 2026).

The single most important concept for an attorney to grasp is limited reserve. A healthy child has enormous physiologic margin to tolerate dehydration, fever, and increased metabolic demand. A single ventricle child has almost none. The same viral illness that is trivial in one child can be lethal in the other.

Why Ordinary Viral Illness Is Dangerous in These Children

The interstage period is uniquely lethal

The interval between stage 1 and stage 2 carries an interstage mortality historically in the range of 10–20% around early infancy (Du Toit et al., Pediatric Cardiology, 2026). The American Heart Association's scientific statement on interstage home monitoring explains that, while many interstage deaths stem from cardiac causes such as shunt obstruction or arch obstruction, intercurrent childhood illness is one of the most common contributors — specifically, acquired gastrointestinal or respiratory illnesses that cause hypovolemia or acute hypoxemia (Rudd et al., Circulation, 2020). In a shunt-dependent circulation, any process that alters systemic vascular resistance, raises metabolic demand, or causes volume depletion can "potentiate progressive hypoxia or shock" (Rudd et al., Circulation, 2020).

Infections are more frequent, more severe, and more deadly in CHD

Children with congenital heart disease contract respiratory infections more often and more severely than healthy peers, owing to a combination of abnormal hemodynamics, hypoxia, chronic inflammation, reduced thymic function, and associated genetic syndromes (Esposito et al., Vaccines, 2025). They have consistently higher rates of hospitalization, ICU admission, mechanical ventilation, and death after respiratory infection (Esposito et al., Vaccines, 2025).

The RSV data make the magnitude concrete. A systematic review and meta-analysis found that, compared with children without CHD, those with underlying CHD who developed RSV lower respiratory infection had roughly 2.2-fold higher odds of severe disease, 3.9-fold higher ICU admission, 4.1-fold higher need for mechanical ventilation, and a strikingly higher case-fatality ratio (Chaw et al., Journal of Infectious Diseases, 2020). Infection is also a leading cause of death in CHD generally, accounting for roughly 10–11% of deaths in infants and children with CHD in one large cohort (Williams et al., Pediatric Cardiology, 2021).

Sepsis risk and the heterotaxy subgroup

Children with pre-existing heart disease are at higher risk both of developing sepsis and of poor outcomes once septic (Weiss et al., Journal of Cardiothoracic and Vascular Anesthesia, 2020). A particularly important subgroup for litigation is heterotaxy — common among single ventricle patients — because asplenia or splenic hypofunction leaves these children susceptible to overwhelming infection with encapsulated bacteria; up to a quarter experience significant sepsis by adulthood, with sepsis-related mortality reported as high as 27–82% (Lui et al., Circulation, 2017). A febrile heterotaxy/asplenia patient is a recognized high-acuity presentation, and failure to appreciate asplenia is a discrete and provable deviation.

A cardiac cause of the fever is actually uncommon — which cuts both ways

In a retrospective study of cyanotic CHD children presenting to the ED with fever, the overwhelming majority had ordinary febrile illnesses (viral syndromes, pneumonia, upper respiratory infection, gastroenteritis, otitis media), and a true cardiac cause of fever such as endocarditis was rare (Tibbles et al., Journal of Emergency Medicine, 2013). Yet because of their limited cardiopulmonary reserve, these children disproportionately required supplemental oxygen, intravenous fluids, and admission — only about half were discharged (Tibbles et al., Journal of Emergency Medicine, 2013). The lesson that matters medicolegally: the diagnosis is usually benign, but the physiology is not, and the disposition decision is therefore different from that of a healthy child.

Why Recognition and Disposition Are Difficult

Several features make these cases genuinely hard — a point relevant to both liability and defense:

• Baseline abnormal vital signs. Many single ventricle children have a chronically reduced baseline oxygen saturation (often in the 75–85% range before Fontan). A saturation that would alarm a clinician in a healthy child may be normal for the patient — and, conversely, a "reassuring" number may represent a dangerous drop from the child's own baseline. Without knowing the baseline, a single reading is uninterpretable.
• Compensated shock. Infants and children maintain blood pressure until late in shock through compensatory tachycardia and vasoconstriction. Normal blood pressure does not exclude shock, and perfusion findings (capillary refill, pulse quality, mental status) often reveal deterioration before blood pressure falls.
• Nonspecific presentation. Poor feeding, sleepiness, and tachypnea are common to both benign viral illness and early decompensation; distinguishing them requires a complete, anatomy-informed assessment.
• Fever imposes real metabolic cost. Fever increases heart rate, respiratory rate, oxygen consumption, and insensible fluid losses — stresses that a child who is cyanotic, has limited reserve, or is becoming septic may not tolerate (Adam, Pediatrics in Review, 2023).

The Evidence on Assessment and Disposition

There is no single randomized trial dictating the exact workup of a febrile single ventricle child, and attorneys should be cautious of experts who overstate the existence of a bright-line "rule." What the literature does establish is a substantially lower threshold for thorough evaluation and admission in this population.

• Single ventricle status independently predicts admission. In a large analysis of ED visits by children with CHD, single-ventricle disease, age under 1 year, and the presence of a complex chronic condition were each independently associated with inpatient admission, and the same high-risk features — infancy, complex CHD — were independently associated with mortality (Edelson et al., JACC, 2018). Presentations with heart failure, cyanosis, arrhythmia, pulmonary hypertension, acute respiratory disease, or acute neurologic disease were more likely to require admission than discharge (Edelson et al., JACC, 2018).
• These children are high-utilization, high-mortality ED patients relative to peers without CHD, with infants and those with comorbid conditions at highest risk (Edelson et al., JACC, 2018).
• Interstage guidance emphasizes structured monitoring and low thresholds. The AHA interstage home-monitoring statement reflects a standard-of-care expectation that these infants are followed with defined surveillance (including oxygen saturation and feeding/weight parameters) and that intercurrent illness triggers prompt evaluation because of its established link to interstage death (Rudd et al., Circulation, 2020).
• Coordination with cardiology is central. Because interpretation of vital signs, saturation, and symptoms depends on the child's specific anatomy and surgical stage, communication with the treating cardiology team is a recurring element of appropriate care.

What this evidence supports, in medical-legal terms, is not that every febrile single ventricle child must be admitted, but that the assessment must be complete and anatomy-aware, and that the threshold to obtain objective data, consult cardiology, and admit is markedly lower than for a healthy child.

Targets for Litigation (Plaintiff Perspective)

The most viable plaintiff theories in these cases are generally the discrete, documentable failures rather than vague "bad outcome" arguments.

• Incomplete assessment / missing objective data. Failure to obtain and document a complete, age-appropriate vital sign set — including heart rate, respiratory rate, temperature, and especially oxygen saturation measured against the child's known baseline — is often the single strongest target. Absence of a documented perfusion examination (capillary refill, pulse quality, mental status, hydration) is similarly central, because perfusion findings detect compensated shock before blood pressure falls.
• Failure to appreciate the significance of the underlying anatomy. Treating a single ventricle infant as though reserve were normal — applying a healthy-child disposition to a shunt-dependent or Fontan patient — is the conceptual core of many claims.
• Failure to check or know the baseline. Not ascertaining the child's baseline oxygen saturation, feeding pattern, and weight, and therefore not recognizing a dangerous deviation.
• Failure to contact or coordinate with cardiology. Given the anatomy-dependence of interpretation, failure to involve the treating cardiac team during an acute illness is a recurring allegation.
• Inadequate reassessment and premature discharge. Discharging without a period of observation, repeat vitals, feeding trial, or documented improvement.
• Failure to recognize red flags and dehydration. Poor feeding, lethargy, tachypnea, and reduced intake carry greater weight in this population because of the direct link between hypovolemia/hypoxemia and interstage collapse (Rudd et al., Circulation, 2020).
• Inadequate return precautions. Failure to give specific, anatomy-aware instructions (e.g., a saturation threshold, feeding minimums, when to call cardiology or return immediately).
• Heterotaxy/asplenia–specific failures. Failure to recognize asplenia and manage fever as a potential encapsulated-organism emergency (Lui et al., Circulation, 2017).
• Documentation deficiencies. Delayed or missing diagnosis and treatment, inadequate monitoring, and insufficient documentation are repeatedly identified drivers of successful pediatric and congenital-cardiac claims (Nikolinakos et al., Annals of the Royal College of Surgeons of England, 2026; Palaniappan & Sellke, Journal of Cardiac Surgery, 2021).

Themes for the Defense

Equally important, several legitimate and evidence-based defenses recur in these cases, and a balanced review must weigh them.

• High baseline mortality independent of care. Single ventricle physiology carries intrinsically high morbidity and mortality at every stage, with interstage death rates of 10–20% and substantial late attrition even after a successful Fontan (Du Toit et al., Pediatric Cardiology, 2026). Many deaths are attributable to the disease, not to any deviation.
• A cardiac cause of fever is genuinely rare. Most febrile presentations are ordinary viral illnesses, and the vast majority are correctly identified as such (Tibbles et al., Journal of Emergency Medicine, 2013); a benign working diagnosis is frequently correct.
• Causation is often contestable. Deterioration can be rapid and, in some cases, would not have been prevented by earlier recognition. The defense can legitimately argue that the intercurrent illness superimposed on fragile physiology produced an outcome that timely, standard care could not have averted — the plaintiff must prove, more likely than not, that different care would have changed the outcome.
• Recognition is genuinely difficult. Baseline-abnormal vitals, compensated shock, and nonspecific early symptoms make real-time recognition hard; hindsight bias must be resisted.
• Compliance and access factors. Missed cardiology appointments, delayed presentation, or failure to follow interstage monitoring instructions at home may be independent or contributing factors.

The strongest defenses are evidentiary: a complete, documented, anatomy-aware assessment with vitals, saturation against baseline, a perfusion exam, a feeding assessment, cardiology coordination, and explicit return precautions will blunt most plaintiff theories even when the outcome is tragic. Conversely, the absence of that documentation is where the defense is weakest — which is why the charting itself so often decides these cases.

Medical Causation

Causation analysis in these cases turns on whether earlier recognition or a different disposition would, more likely than not, have changed the outcome. Key questions include:

• Was the deterioration driven by a reversible, time-dependent process (hypovolemia from poor feeding, hypoxemia, evolving sepsis) that earlier intervention could have interrupted (Rudd et al., Circulation, 2020; Weiss et al., 2020)?
• Or did the child suffer a sudden, shunt-related or arrhythmic event that would have occurred regardless (Marino et al., Circulation, 2018)?
• Was there a window in which admission, fluids, oxygen, or antibiotics would have altered the trajectory — and was that window missed?
• Does the autopsy or final clinical picture identify a mechanism (e.g., dehydration-induced shunt thrombosis, overwhelming sepsis, hypoxemia) that ties the deviation to the death?

Because the disease itself carries high baseline mortality, causation — not breach — is frequently the decisive battleground.

Long-Term Outcomes and Damages

In survivors, the damages landscape reflects the lifelong burden of the physiology:

• Neurologic injury from hypoxic-ischemic events or shock
• Developmental delay
• End-organ dysfunction (hepatic, renal), protein-losing enteropathy, plastic bronchitis, arrhythmia
• Need for further surgery, transplantation evaluation, or chronic intensive care
• Reduced quality of life and shortened life expectancy
• In fatal cases, wrongful-death claims, which in the congenital-cardiac litigation experience are common and associated with substantial awards and settlements (Palaniappan & Sellke, Journal of Cardiac Surgery, 2021)

A credible damages analysis must separate the injury attributable to any deviation from the morbidity the child would have faced from the underlying lesion regardless.

Medical Records That Matter

Isolated records rarely tell the story. Meaningful review usually requires:

• The full cardiac surgical history (operative notes for each stage) and current surgical stage
• Cardiology clinic notes establishing baseline oxygen saturation, feeding pattern, weight trajectory, and ventricular function
• Interstage home-monitoring records (saturation and weight logs), where applicable
• Triage and nursing notes, with vital-sign trends and documented perfusion/hydration assessments
• The index encounter: documented vitals, saturation, exam, feeding assessment, reassessments, and timing
• Any communication (or lack thereof) with the cardiology team
• Discharge instructions and return precautions actually given
• Timing of fluids, antibiotics, and escalation in the fatal or deterioration sequence
• Autopsy report in fatal cases

The Role of Pediatric and Pediatric Cardiology Expertise

Evaluating these cases requires expertise beyond general pediatrics or adult cardiology. The interpretation of a vital sign, a saturation reading, or a feeding history depends entirely on the child's specific anatomy and surgical stage — an oxygen saturation of 80% may be perfectly normal or frankly alarming depending on the circulation. An expert with training in both general pediatrics and pediatric/congenital cardiology can explain what the baseline should have been, whether the assessment met the standard for this specific physiology, whether the disposition was reasonable, and — critically — whether earlier action would more likely than not have changed the outcome.

Key Takeaways for Attorneys

• Single ventricle physiology (including HLHS) means one working pumping chamber and minimal physiologic reserve; common illnesses that are trivial in healthy children can be lethal.
• The interstage period carries 10–20% mortality, and intercurrent viral and GI illness causing dehydration or hypoxemia is a leading contributor (Rudd et al., Circulation, 2020; Du Toit et al., 2026).
• Children with CHD have far more severe outcomes from common viruses — RSV, for example, carries markedly higher ICU, ventilation, and fatality rates (Chaw et al., Journal of Infectious Diseases, 2020).
• Single ventricle status independently predicts both admission and mortality in the ED (Edelson et al., JACC, 2018); the threshold for evaluation and admission is far lower than for healthy children.
• A cardiac cause of fever is rare, but the limited reserve means these children disproportionately need oxygen, fluids, and admission (Tibbles et al., Journal of Emergency Medicine, 2013) — a point that cuts for both sides.
• The strongest plaintiff targets are discrete failures: incomplete vitals (especially oxygen saturation vs. baseline), no documented perfusion exam, failure to appreciate the anatomy, no cardiology coordination, premature discharge, and inadequate return precautions.
• The strongest defenses are high intrinsic mortality, contestable causation, genuine difficulty of recognition, and — above all — complete, anatomy-aware documentation.
• Heterotaxy/asplenia patients are a special high-acuity subgroup in whom fever is a potential overwhelming-sepsis emergency (Lui et al., Circulation, 2017).
• Causation, not breach, is often decisive, because the disease itself carries high baseline mortality; the plaintiff must show that different care would more likely than not have changed the outcome.
• The chart frequently decides the case: documented vitals, saturation, perfusion, feeding, and cardiology communication protect the defense, while their absence is the plaintiff's opening.

References

• Adam, Pediatrics in Review, 2023.
• Chaw et al., Journal of Infectious Diseases, 2020.
• Du Toit et al., Pediatric Cardiology, 2026.
• Edelson et al., JACC, 2018.
• Esposito et al., Vaccines, 2025.
• Lui et al., Circulation, 2017.
• Marino et al., Circulation, 2018.
• Nikolinakos et al., Annals of the Royal College of Surgeons of England, 2026.
• Rudd et al., Circulation, 2020.
• Palaniappan & Sellke, Journal of Cardiac Surgery, 2021.
• Tibbles et al., Journal of Emergency Medicine, 2013.
• Weiss et al., Journal of Cardiothoracic and Vascular Anesthesia, 2020.
• Williams et al., Pediatric Cardiology, 2021.